Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Mar 9, 2020 7:00 PM ET

Wearable Injectors Market worth $9.41 Billion by 2023, at a CAGR of 11.1%




iCrowd Newswire - Mar 9, 2020

The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period (2018-2023). The key factors driving the growth of this market are the growing prevalence of chronic diseases (such as cancer, diabetes, and cardiovascular diseases), favorable reimbursement scenario in major markets, and technological advancements in injector devices.

Download PDF [email protected]
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

By type, the on-body injectors segment is expected to account for the largest market share in 2018

On the basis of type, the wearable injectors market is segmented into on-body and off-body injectors. The on-body injectors segment is expected to account for the larger market share in 2018, while the off-body injectors segment is projected to witness the highest growth rate during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased adoption of off-body injectors.

wearable-injector-market2

By therapy, the immune-oncology segment is expected to account for the largest market share in 2018

On the basis of therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s disease, thalassemia, and primary immunodeficiency disorders). In 2018, the immune-oncology segment is expected to account for the largest share of the wearable injectors market. This can be attributed to the high prevalence of cancer across the globe.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004

North America to dominate the market in 2018

In 2018, North America is expected to account for the largest share of the wearable injectors market, followed by Europe. Factors such as availability of technologically advanced wearable injector systems for various therapeutic areas such as cancer, diabetes, and cardiovascular diseases; the presence of major market players in the region; and a favorable reimbursement scenario in the US and Canada are contributing to the large share of North America.



Contact Information:

Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441






Keywords:    Wearable Injectors Market, Wearable Injectors Market Share, Wearable Injectors, Wearable Injectors Market Analysis

Tags:    Extended Distribution, Wire, Research Newswire, English